Thus, though some general anti-tumour effect was noted, possibly mediated by inhibition of angiogenesis (VEGFR2), Pz-1 efficacy correlated with the positivity for RET and TRKA oncoproteins. The gene discussed is NTRK1; the disease is neoplasm.